Indianapolis-based drugmaker Eli Lilly and Company has announced price reductions of 70% for its most commonly prescribed insulins, as well as expansion of its Insulin Value Program, capping patient ...
2-Year U.S. Treasury Note Continuous Contract $103.527-0.152-0.15% 5-Year U.S. Treasury Note Continuous Contract $107.820-0.266-0.25% 10-Year U.S. Treasury Note Continuous Contract $110.547-0.375-0.34 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results